-DOCSTART- -X- O
INTRODUCTION -X- _ O
: -X- _ O
Diffuse -X- _ B-Intervention
alveolar -X- _ I-Intervention
damage -X- _ I-Intervention
( -X- _ I-Intervention
DAD -X- _ I-Intervention
) -X- _ I-Intervention
is -X- _ O
the -X- _ O
pathological -X- _ O
hallmark -X- _ O
of -X- _ O
acute -X- _ O
respiratory -X- _ O
distress -X- _ O
syndrome -X- _ O
( -X- _ O
ARDS -X- _ O
) -X- _ O
, -X- _ O
however -X- _ O
, -X- _ O
the -X- _ O
presence -X- _ O
of -X- _ O
DAD -X- _ B-Intervention
in -X- _ O
the -X- _ O
clinical -X- _ O
criteria -X- _ O
of -X- _ O
ARDS -X- _ O
patients -X- _ O
by -X- _ O
Berlin -X- _ O
definition -X- _ O
is -X- _ O
little -X- _ O
known. -X- _ O
This -X- _ O
study -X- _ O
is -X- _ O
designed -X- _ O
to -X- _ O
investigate -X- _ O
the -X- _ O
role -X- _ O
of -X- _ O
DAD -X- _ B-Intervention
in -X- _ O
ARDS -X- _ B-Patient
patients -X- _ I-Patient
who -X- _ I-Patient
underwent -X- _ I-Patient
open -X- _ I-Patient
lung -X- _ I-Patient
biopsy. -X- _ I-Patient
METHODS -X- _ O
: -X- _ O
We -X- _ O
retrospectively -X- _ O
reviewed -X- _ O
all -X- _ O
ARDS -X- _ O
patients -X- _ O
who -X- _ O
met -X- _ O
the -X- _ O
Berlin -X- _ O
definition -X- _ O
and -X- _ O
underwent -X- _ O
open -X- _ O
lung -X- _ O
biopsy -X- _ O
from -X- _ O
January -X- _ O
1999 -X- _ O
to -X- _ O
January -X- _ O
2014 -X- _ O
in -X- _ O
a -X- _ O
referred -X- _ O
medical -X- _ O
center. -X- _ O
DAD -X- _ O
is -X- _ O
characterized -X- _ O
by -X- _ O
hyaline -X- _ O
membrane -X- _ O
formation -X- _ O
, -X- _ O
lung -X- _ O
edema -X- _ O
, -X- _ O
inflammation -X- _ O
, -X- _ O
hemorrhage -X- _ O
and -X- _ O
alveolar -X- _ O
epithelial -X- _ O
cell -X- _ O
injury. -X- _ O
Clinical -X- _ O
data -X- _ O
including -X- _ O
baseline -X- _ O
characteristics -X- _ O
, -X- _ O
severity -X- _ O
of -X- _ O
ARDS -X- _ O
, -X- _ O
clinical -X- _ O
and -X- _ O
pathological -X- _ O
diagnoses -X- _ O
, -X- _ O
and -X- _ O
survival -X- _ O
outcomes -X- _ O
were -X- _ O
analyzed. -X- _ O
RESULTS -X- _ O
: -X- _ O
A -X- _ O
total -X- _ O
of -X- _ O
1838 -X- _ O
patients -X- _ O
with -X- _ O
ARDS -X- _ O
were -X- _ O
identified -X- _ O
and -X- _ O
open -X- _ O
lung -X- _ O
biopsies -X- _ O
were -X- _ O
performed -X- _ O
on -X- _ O
101 -X- _ B-Patient
patients -X- _ I-Patient
( -X- _ I-Patient
5.5 -X- _ I-Patient
% -X- _ I-Patient
) -X- _ I-Patient
during -X- _ O
the -X- _ O
study -X- _ O
period. -X- _ O
Of -X- _ B-Outcome
these -X- _ I-Outcome
101 -X- _ I-Outcome
patients -X- _ I-Outcome
, -X- _ I-Outcome
the -X- _ I-Outcome
severity -X- _ I-Outcome
of -X- _ I-Outcome
ARDS -X- _ I-Outcome
on -X- _ I-Outcome
diagnosis -X- _ I-Outcome
was -X- _ I-Outcome
mild -X- _ I-Outcome
of -X- _ I-Outcome
16.8 -X- _ I-Outcome
% -X- _ I-Outcome
, -X- _ I-Outcome
moderate -X- _ I-Outcome
of -X- _ I-Outcome
56.5 -X- _ I-Outcome
% -X- _ I-Outcome
and -X- _ I-Outcome
severe -X- _ I-Outcome
of -X- _ I-Outcome
26.7 -X- _ I-Outcome
% -X- _ I-Outcome
. -X- _ I-Outcome
The -X- _ I-Outcome
hospital -X- _ I-Outcome
mortality -X- _ I-Outcome
rate -X- _ I-Outcome
was -X- _ I-Outcome
not -X- _ I-Outcome
significant -X- _ I-Outcome
difference -X- _ I-Outcome
between -X- _ I-Outcome
the -X- _ I-Outcome
three -X- _ I-Outcome
groups -X- _ I-Outcome
( -X- _ I-Outcome
64.7 -X- _ I-Outcome
% -X- _ I-Outcome
vs -X- _ I-Outcome
61.4 -X- _ I-Outcome
% -X- _ I-Outcome
vs -X- _ I-Outcome
55.6 -X- _ I-Outcome
% -X- _ I-Outcome
, -X- _ I-Outcome
p -X- _ I-Outcome
= -X- _ I-Outcome
0.81 -X- _ I-Outcome
) -X- _ I-Outcome
. -X- _ I-Outcome
Of -X- _ I-Outcome
the -X- _ I-Outcome
101 -X- _ I-Outcome
clinical -X- _ I-Outcome
ARDS -X- _ I-Outcome
patients -X- _ I-Outcome
with -X- _ I-Outcome
open -X- _ I-Outcome
lung -X- _ I-Outcome
biopsies -X- _ I-Outcome
, -X- _ I-Outcome
56.4 -X- _ I-Outcome
% -X- _ I-Outcome
( -X- _ I-Outcome
57 -X- _ I-Outcome
/ -X- _ I-Outcome
101 -X- _ I-Outcome
) -X- _ I-Outcome
patients -X- _ I-Outcome
had -X- _ I-Outcome
DAD -X- _ I-Outcome
according -X- _ I-Outcome
to -X- _ I-Outcome
biopsy -X- _ I-Outcome
results. -X- _ I-Outcome
The -X- _ I-Outcome
proportion -X- _ I-Outcome
of -X- _ I-Outcome
DAD -X- _ I-Outcome
were -X- _ I-Outcome
76.5 -X- _ I-Outcome
% -X- _ I-Outcome
( -X- _ I-Outcome
13 -X- _ I-Outcome
/ -X- _ I-Outcome
17 -X- _ I-Outcome
) -X- _ I-Outcome
in -X- _ I-Outcome
mild -X- _ I-Outcome
, -X- _ I-Outcome
56.1 -X- _ I-Outcome
% -X- _ I-Outcome
( -X- _ I-Outcome
32 -X- _ I-Outcome
/ -X- _ I-Outcome
57 -X- _ I-Outcome
) -X- _ I-Outcome
in -X- _ I-Outcome
moderate -X- _ I-Outcome
and -X- _ I-Outcome
44.4 -X- _ I-Outcome
% -X- _ I-Outcome
( -X- _ I-Outcome
12 -X- _ I-Outcome
/ -X- _ I-Outcome
27 -X- _ I-Outcome
) -X- _ I-Outcome
in -X- _ I-Outcome
severe -X- _ I-Outcome
ARDS -X- _ I-Outcome
and -X- _ I-Outcome
there -X- _ I-Outcome
is -X- _ I-Outcome
no -X- _ I-Outcome
significant -X- _ I-Outcome
difference -X- _ I-Outcome
between -X- _ I-Outcome
the -X- _ I-Outcome
three -X- _ I-Outcome
groups -X- _ I-Outcome
( -X- _ I-Outcome
p -X- _ I-Outcome
= -X- _ I-Outcome
0.113 -X- _ I-Outcome
) -X- _ I-Outcome
. -X- _ I-Outcome
Pathological -X- _ I-Outcome
findings -X- _ I-Outcome
of -X- _ I-Outcome
DAD -X- _ I-Outcome
patients -X- _ I-Outcome
had -X- _ I-Outcome
a -X- _ I-Outcome
higher -X- _ I-Outcome
hospital -X- _ I-Outcome
mortality -X- _ I-Outcome
rate -X- _ I-Outcome
than -X- _ I-Outcome
non-DAD -X- _ I-Outcome
patients -X- _ I-Outcome
( -X- _ I-Outcome
71.9 -X- _ I-Outcome
% -X- _ I-Outcome
vs -X- _ I-Outcome
45.5 -X- _ I-Outcome
% -X- _ I-Outcome
, -X- _ I-Outcome
p -X- _ I-Outcome
= -X- _ I-Outcome
0.007 -X- _ I-Outcome
) -X- _ I-Outcome
. -X- _ I-Outcome
Pathological -X- _ I-Outcome
findings -X- _ I-Outcome
of -X- _ I-Outcome
DAD -X- _ I-Outcome
( -X- _ I-Outcome
odds -X- _ I-Outcome
ratio -X- _ I-Outcome
: -X- _ I-Outcome
3.554 -X- _ I-Outcome
, -X- _ I-Outcome
95 -X- _ I-Outcome
% -X- _ I-Outcome
CI -X- _ I-Outcome
, -X- _ I-Outcome
1.385–9.12 -X- _ I-Outcome
; -X- _ I-Outcome
p -X- _ I-Outcome
= -X- _ I-Outcome
0.008 -X- _ I-Outcome
) -X- _ I-Outcome
and -X- _ I-Outcome
Sequential -X- _ I-Outcome
Organ -X- _ I-Outcome
Failure -X- _ I-Outcome
Assessment -X- _ I-Outcome
score -X- _ I-Outcome
on -X- _ I-Outcome
the -X- _ I-Outcome
biopsy -X- _ I-Outcome
day -X- _ I-Outcome
( -X- _ I-Outcome
odds -X- _ I-Outcome
ratio -X- _ I-Outcome
: -X- _ I-Outcome
1.424 -X- _ I-Outcome
, -X- _ I-Outcome
95 -X- _ I-Outcome
% -X- _ I-Outcome
CI -X- _ I-Outcome
, -X- _ I-Outcome
1.187– -X- _ I-Outcome
1.707 -X- _ I-Outcome
; -X- _ I-Outcome
p -X- _ I-Outcome
< -X- _ I-Outcome
0.001 -X- _ I-Outcome
) -X- _ I-Outcome
were -X- _ I-Outcome
significantly -X- _ I-Outcome
and -X- _ I-Outcome
independently -X- _ I-Outcome
associated -X- _ I-Outcome
with -X- _ I-Outcome
hospital -X- _ I-Outcome
mortality. -X- _ I-Outcome
The -X- _ I-Outcome
baseline -X- _ I-Outcome
demographics -X- _ I-Outcome
and -X- _ I-Outcome
clinical -X- _ I-Outcome
characteristics -X- _ I-Outcome
were -X- _ I-Outcome
not -X- _ I-Outcome
significantly -X- _ I-Outcome
different -X- _ I-Outcome
between -X- _ I-Outcome
DAD -X- _ I-Outcome
and -X- _ I-Outcome
non-DAD -X- _ I-Outcome
patients. -X- _ I-Outcome
CONCLUSIONS -X- _ O
: -X- _ O
The -X- _ O
correlation -X- _ O
of -X- _ O
pathological -X- _ O
findings -X- _ O
of -X- _ O
DAD -X- _ O
and -X- _ O
ARDS -X- _ O
diagnosed -X- _ O
by -X- _ O
Berlin -X- _ O
definition -X- _ O
is -X- _ O
modest. -X- _ O
A -X- _ B-Outcome
pathological -X- _ I-Outcome
finding -X- _ I-Outcome
of -X- _ I-Outcome
DAD -X- _ I-Outcome
in -X- _ I-Outcome
ARDS -X- _ I-Outcome
patients -X- _ I-Outcome
is -X- _ I-Outcome
associated -X- _ I-Outcome
with -X- _ I-Outcome
hospital -X- _ I-Outcome
mortality -X- _ I-Outcome
and -X- _ I-Outcome
there -X- _ I-Outcome
are -X- _ I-Outcome
no -X- _ I-Outcome
clinical -X- _ I-Outcome
characteristics -X- _ I-Outcome
that -X- _ I-Outcome
could -X- _ I-Outcome
identify -X- _ I-Outcome
DAD -X- _ I-Outcome
patients -X- _ I-Outcome
before -X- _ I-Outcome
open -X- _ I-Outcome
lung -X- _ I-Outcome
biopsy -X- _ I-Outcome
. -X- _ O

